HRT Patient Assistance Programs: Which Doors Are Open in 2026, and Which One Is Yours?

Yes—HRT patient assistance programs can provide free medication or real savings, but your route depends on the exact prescription, plan coverage, insurance type, and household income. Pfizer and Bayer have free-drug routes for some FDA-approved hormone products; Astellas has one for nonhormonal Veozah. Medicare users usually start with Extra Help, not a standard copay card.

Best for: women who were handed a pharmacy price they cannot pay, lost coverage for a menopause medication, have no insurance, or had a savings offer fail at the counter.

Not for you if: your main problem is paying for the consultation, membership, laboratory work, or follow-up care. Prescription assistance usually does not pay those bills. Start with HRT Cost in 2026 instead.

You are in the wrong place if: you are looking for help paying for gender-affirming hormone therapy. That is a different assistance system. Start with the Point of Pride HRT Access Fund or FOLX's current HRT Care Fund information. We would rather send you to the right system now than waste your afternoon.

Start here: which assistance door matches your insurance?

Answer capsule: Your first move is not determined by insurance alone. It is determined by insurance plus whether the exact drug is covered. Bayer can help some patients whose Bayer medicine is not covered, Pfizer excludes commercial insurance, and most standard copay cards require commercial coverage for the exact brand.

Your situation	Doors that may be open	Your first move today
No insurance	Pfizer Patient Assistance Program; Bayer US Patient Assistance Foundation; Astellas Patient Assistance Program for Veozah; nonprofit pharmacies; community health centers	Find your exact medicine in the census below, then check the manufacturer's eligibility rules
Medicare Part D or Medicare Advantage	Extra Help; Medicare Savings Programs; state pharmaceutical assistance; Pfizer's free-drug program for eligible patients; limited manufacturer opt-out coupons for Bijuva, Imvexxy, or Femring	Apply for Extra Help first; then check the exact medicine route
Commercial insurance and the drug is covered	A standard manufacturer copay card may lower your share	Download the current card from the manufacturer, then ask the pharmacy to compare three prices
Commercial insurance and the drug is excluded	A formulary exception; Bayer's free-drug program for an eligible Bayer medicine; cash or generic alternatives	File the coverage exception first; check Bayer separately if it makes your exact drug
Medicaid, TRICARE, or VA coverage	Plan appeal; Pfizer's free-drug program for eligible patients; Bayer assistance when the exact Bayer medicine is not covered	Start with the plan formulary and exception process, then check the manufacturer program

The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.

The rules are real. They are also scattered across manufacturer eligibility pages, product lists, savings-card PDFs, Medicare guidance, Social Security tables, and pharmacy claim terms. This page puts the doors in one order so you can stop opening the ones that were never built for you.

→ Use the HRT Assistance Door Finder. It gives you a likely route from three nonmedical facts: your exact medicine, your insurance type, and whether your plan covers it. It never decides eligibility; only the program can do that.

Before you go further

The right online HRT provider isn't the same for every woman — it depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state. Some situations belong with an in-person clinician first. Because a general answer can't resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider — and to flag when online care isn't the right starting point — before your first consult.

First, make sure you are on the right HRT assistance page

Answer capsule: “HRT” is used for two different kinds of care with separate assistance systems. Menopause hormone therapy assistance runs through drug manufacturers, Medicare, coverage appeals, pharmacies, and charitable funds. Gender-affirming hormone therapy assistance runs through different nonprofit funds and care programs. This page covers menopause care only.

Two people can type the same search phrase and need completely different applications. A woman trying to keep filling Estring should not spend an hour inside a grant process built for gender-affirming care, and a transgender person should not be routed through a Premarin manufacturer form that does not solve their access problem.

That is why the split appears before the program list instead of in a footnote.

What are HRT patient assistance programs, exactly?

Answer capsule: “Assistance” can mean eight different things. A manufacturer program may provide free medicine. A commercial copay card reduces an insured patient's share. A Medicare opt-out coupon bypasses the drug plan and sacrifices plan credit. A charity grant pays part of a covered drug. Confusing those routes wastes weeks.

What it is called	What it actually does	Who it is built for	Free medicine?	The catch
Manufacturer patient assistance program (PAP)	Supplies a named manufacturer's drug to an approved patient	Eligibility varies: uninsured, government-insured, or patients whose exact drug is not covered, depending on the manufacturer	Yes	Income, prescription, coverage, geography, and documentation rules apply
Standard manufacturer copay card	Reduces what the patient owes after a commercial plan processes a covered claim	Commercially insured patients who meet the card terms	No	Government programs are excluded; per-fill and annual caps may apply
Cash-pay manufacturer offer	Discounts a prescription processed without insurance	Eligible cash-paying patients	No	It does not create insurance coverage and cannot be combined with another discount
Medicare Part D alternative or opt-out coupon	Lets an eligible Part D member buy a named drug outside the plan	A narrow group using Bijuva, Imvexxy, or Femring under current terms	No	No plan reimbursement and no true out-of-pocket, or TrOOP, credit for that purchase
Cash discount coupon	Quotes a cash price through a discount network	Someone choosing not to use insurance for that transaction	No	It cannot be combined with insurance or a manufacturer card
Charitable foundation grant	Pays some copay, coinsurance, premium, or other covered cost allowed by the fund	Insured patients who meet the fund's disease, treatment, and income rules	No	The treatment must be covered and funds can close without notice
Government help	Reduces Medicare premiums, deductibles, copays, or other costs	Eligible Medicare or Medicaid beneficiaries	No, but the savings can be larger	Income, resources, residence, or enrollment rules apply
Medicare Prescription Payment Plan	Spreads Part D out-of-pocket costs across the remaining months of the year	Medicare Part D or Advantage drug-plan members	No	It is not a discount. You owe the same total.

Two sentences are worth reading twice:

A manufacturer PAP supplies a particular company's medicine. A charitable foundation grant helps pay a covered treatment through insurance. They can both be called “patient assistance,” but they do opposite jobs. An uninsured patient cannot use a grant that requires active coverage, and an insured patient cannot assume a manufacturer's free-drug program accepts that insurance type.

Which HRT patient assistance programs are open in 2026?

Answer capsule: The current manufacturer landscape is uneven. Pfizer lists seven menopause or estrogen products in its July 2026 free-medicine PDF. Bayer's two official rosters conflict on Angeliq and Lynkuet. Astellas has a Veozah route for eligible uninsured patients. Several other brands have cards or opt-out coupons, not free-drug programs.

The 2026 Menopause Medication Assistance Census

Medication	Product type	Manufacturer free-drug route	Commercial or cash route	Medicare or government route	Verified first move
Premarin tablets	FDA-approved conjugated estrogens	Yes. Listed separately in Pfizer's July 2026 PAP PDF	Pfizer publishes up to $120 per fill under its commercial menopause card	Pfizer PAP may accept eligible government-insured patients; covered Part D users face Pfizer's MPPP rules	Check Pfizer RxPathways
Premarin Vaginal Cream	FDA-approved conjugated estrogens vaginal cream	Yes. The July 2026 PDF separately names the cream	Pfizer publishes up to $250 per fill	Same Pfizer government-insurance and Part D conditions	Use the current Pfizer PAP medicine PDF, not a roster that collapses both Premarin products into one name
Prempro	FDA-approved conjugated estrogens/medroxyprogesterone acetate	Yes	Pfizer publishes up to $110 per fill	Pfizer PAP may accept eligible government-insured patients	Check the current Pfizer menopause card terms before filling
Premphase	FDA-approved conjugated estrogens/medroxyprogesterone acetate	Yes	No current Pfizer menopause-card benefit was found for Premphase	Pfizer PAP may accept eligible government-insured patients	Start with the PAP, not a card search
Duavee	FDA-approved conjugated estrogens/bazedoxifene	Yes	Pfizer publishes up to $110 per fill	Pfizer PAP may accept eligible government-insured patients	Check PAP eligibility and the current commercial card separately
Estring	FDA-approved estradiol vaginal ring	Yes	Pfizer publishes up to $360 per fill	Pfizer PAP may accept eligible government-insured patients	Confirm plan coverage before expecting the card to process
Depo-Estradiol	FDA-approved estradiol cypionate injection	Yes	Not listed on Pfizer's current menopause card	Pfizer PAP may accept eligible government-insured patients	Use the free-drug program route
Angeliq	FDA-approved drospirenone/estradiol	Official Bayer conflict. The live Find Help tool lists it; Bayer's dated product page does not	No exact current manufacturer savings amount was verified	Bayer may help when the exact drug is not covered and other requirements are met	Call Bayer at 1-866-228-7723 before relying on the roster
Climara Pro	FDA-approved estradiol/levonorgestrel patch	Yes. It appears on both current Bayer rosters	Bayer publishes as little as $25 for eligible insured, covered patients, with up to $50 monthly savings; eligible cash-paying patients may get up to $75 off per prescription, subject to a $1,000 annual maximum	Bayer may help when the exact drug is not covered and eligibility rules are met	Check the Bayer Foundation Find Help tool and current savings details separately
Menostar	FDA-approved 14 mcg/day estradiol patch for prevention of postmenopausal osteoporosis	Yes. It appears on both Bayer rosters	No current Menostar manufacturer card was found	Bayer may help when the exact drug is not covered and eligibility rules are met	Do not confuse Menostar with plain Climara or Climara Pro; verify the indication in the current label
Lynkuet	FDA-approved nonhormonal treatment for moderate to severe vasomotor symptoms	Official Bayer conflict. Bayer's dated product page and launch material include it; the live Find Help tool does not	Bayer publishes a patient-support route; check the live terms at the time of use	Call Bayer to confirm whether the Foundation is currently accepting this product	Do not call Lynkuet HRT; it is included because women searching this page also need hot-flash affordability routes
Veozah	FDA-approved nonhormonal treatment for moderate to severe vasomotor symptoms	Eligible uninsured patients may receive it for $0 through Astellas' program	Current commercial terms publish a $0 first fill, refills as low as $30, and an annual maximum of up to $4,000	Standard commercial terms exclude government claims; Astellas directs Medicare or Medicaid patients to call for possible support routes	Check Veozah Support Solutions or call 1-866-239-1637
Bijuva	FDA-approved estradiol/progesterone capsule	No current manufacturer free-drug PAP was found	Commercial card requires the plan to cover Bijuva; the manufacturer publishes “maximum limitations apply” but no universal dollar floor or cap	A separate Part D alternative coupon may apply if coverage or out-of-pocket conditions are met; use means opting out for the drug and losing TrOOP credit	Read the current Mayne coupon terms before paying
Imvexxy	FDA-approved estradiol vaginal insert	No current manufacturer free-drug PAP was found	Commercial card requires the plan to cover Imvexxy; no universal dollar floor or cap is published	A separate Part D alternative coupon may apply; it also requires opting out for the drug and losing TrOOP credit	Treat the commercial card and Medicare coupon as two different programs
Femring	FDA-approved estradiol acetate vaginal ring	No current manufacturer free-drug PAP was found	The brand site links to a separate commercial savings program; verify the live amount	The current Medicare program says most eligible users may pay as little as $190 for one 90-day ring, with no plan reimbursement or TrOOP credit	Read Femring's Medicare terms before opting out
CombiPatch	FDA-approved estradiol/norethindrone acetate patch	No current manufacturer free-drug PAP was found	Manufacturer asset conflict: parsed July 2026 terms say cash-pay only and $75 off; the rendered PDF can still show a January 2026 $25 offer for commercial and cash patients	Government programs are excluded under both versions	Check the revision date in the current manufacturer asset and call 1-833-483-2178 before relying on either number
Vagifem	FDA-approved estradiol vaginal insert	Not listed on Novo Nordisk's current patient-assistance roster checked in August 2026	No current manufacturer savings route was verified	Use plan coverage, an appeal, or a live cash comparison	Do not assume the generic Yuvafem has the same manufacturer program
Estrace Vaginal Cream	FDA-approved estradiol vaginal cream	Not listed on AbbVie's current patient-assistance or savings rosters checked in August 2026	No current manufacturer savings route was verified	Use plan coverage, an appeal, or a live cash comparison	Check the exact generic strength and quantity before paying brand cash prices

Generic estradiol and generic micronized progesterone are not counted as separate census brands. They usually belong in the cash-price and formulary-comparison lane, not a manufacturer PAP. Compare the exact drug, strength, quantity, pharmacy, shipping charge, and coupon terms live. A lower cash price is never a reason to change medication, dose, or route without the prescriber who wrote it.

Four findings worth carrying with you

1. Pfizer's current free-medicine roster contains seven relevant products, not six. Its July 2026 PDF names Premarin tablets and Premarin Vaginal Cream separately. A shorter Pfizer webpage collapses the name to “Premarin,” which is exactly how the cream gets lost in summaries.

2. Bayer's own current rosters do not match. Its Find Help tool includes Angeliq, Climara Pro, and Menostar. Its product page, dated January 9, 2026, includes Climara Pro, Lynkuet, and Menostar. That is not a detail to smooth over. Call before you build a plan around Angeliq or Lynkuet.

3. Veozah and Lynkuet are not hormone therapy. They are included because a woman trying to afford treatment for hot flashes may be deciding between hormone and nonhormonal prescriptions, and a useful affordability page cannot pretend those expensive alternatives do not exist.

4. The Bijuva, Imvexxy, and Femring Medicare routes are opt-out coupons—not ordinary copay cards. The purchase does not go through the Part D plan, the plan does not reimburse it, and the spending does not count toward TrOOP. That tradeoff belongs next to the advertised price, not buried after it.

→ Found your medicine? Go to the program that actually owns the route. Pfizer: 1-844-989-7284. Bayer: 1-866-228-7723. Astellas/Veozah: 1-866-239-1637. Applying directly is free.

Who qualifies for the Pfizer Patient Assistance Program in 2026?

Answer capsule: Pfizer's 2026 PAP is for patients at or below 300% of the federal poverty level who are uninsured or government-insured, cannot afford the cost, and have a valid prescription for a listed Pfizer medicine and an FDA-approved indication. Commercial insurance disqualifies the patient even when the plan pays nothing.

Pfizer's current rules are unusually specific. To be considered, you must:

• Have annual pre-tax household income at or below 300% of the federal poverty level.
• Be uninsured or government-insured and unable to afford the required cost. Pfizer names Medicare, Medicaid, TRICARE, and VA coverage as examples of government insurance.
• Not have commercial insurance. A commercial plan disqualifies you even when the plan excludes the drug.
• Have a valid prescription for a Pfizer medicine currently available in the PAP.
• Have that prescription for an FDA-approved indication.
• Live in the United States, Puerto Rico, the U.S. Virgin Islands, or Guam and be treated by a clinician licensed in the United States or a covered territory.
• Work through any prior authorization required by the plan.
• Apply to relevant alternate funding sources first. Pfizer may require denial documentation.

The seven relevant products in Pfizer's July 2026 free-medicine PDF are Depo-Estradiol, Duavee, Estring, Premarin tablets, Premarin Vaginal Cream, Premphase, and Prempro.

The Medicare rule that can stop a Pfizer form

A Medicare Part D or Medicare Advantage member requesting help with a Pfizer product that the plan covers must enroll in the voluntary Medicare Prescription Payment Plan and provide proof. Pfizer says missing proof prevents processing for applicants above 138% of the poverty level. The applicant must also attest that she knows the copay and annual out-of-pocket maximum, cannot afford the copay, and has not yet reached the $2,100 annual Part D limit for covered medicines.

Pfizer calls this program a last-resort safety net. That is why the order on this page starts with Extra Help, plan coverage, and available outside funding before the Pfizer application.

→ If your medicine is on Pfizer's list and your situation fits, start at Pfizer RxPathways or call 1-844-989-PATH (7284). Already enrolled? Call 1-866-706-2400.

What is the income limit for HRT patient assistance in 2026?

Answer capsule: Pfizer uses 300% of the 2026 federal poverty level. Bayer says the limit is 300% for most medicines. That equals $47,880 for one person and $64,920 for two in the 48 contiguous states and Washington, D.C. Alaska and Hawaii use higher federal schedules.

People in household	48 states + D.C.	Alaska	Hawaii
1	$47,880	$59,850	$55,080
2	$64,920	$81,150	$74,670
3	$81,960	$102,450	$94,260
4	$99,000	$123,750	$113,850
5	$116,040	$145,050	$133,440
6	$133,080	$166,350	$153,030
7	$150,120	$187,650	$172,620
8	$167,160	$208,950	$192,210
Each additional person	+$17,040	+$21,300	+$19,590

Source: the 2026 HHS poverty guidelines, multiplied by 300%.

This is a screening table, not an approval. Each program defines household and income under its own rules and decides what documents it will accept.

One stale number can quietly cost someone a year of medicine. A one-person Pfizer applicant who earns $47,000 is under the correct 2026 line. A page still using the 2025 300% figure of $46,950 would wrongly tell her she is over it.

Astellas does not publish a universal Veozah PAP income percentage on its public support page. Do not borrow Pfizer's or Bayer's 300% threshold and paste it onto Veozah. Call Astellas for the current screening rules.

→ Use the HRT Assistance Door Finder to place your household against the right 2026 line, then let the program make the decision.

The HRT Assistance Door Finder

Answer capsule: You need three facts: the exact prescription, your insurance type, and whether that plan covers the drug. Income comes next for free-drug and government programs. The routes below are ordered to protect the most valuable benefits first and keep an opt-out coupon from accidentally costing you Medicare credit.

Your answers	Likely first route	Why it comes first
Uninsured + Pfizer medicine + income at or below 300% FPL	Pfizer PAP	Current Pfizer rules expressly accept eligible uninsured patients
Uninsured, or exact medicine not covered + Bayer medicine + income within Bayer's rule	Bayer Foundation	Bayer screens both no-insurance and not-covered situations
Uninsured + Veozah	Astellas PAP screening	Eligible uninsured patients may receive Veozah for $0
Medicare + income/resources near the Extra Help limits	Extra Help	It can reduce costs across covered Part D drugs without opting out of the plan
Medicare + Pfizer medicine + income at or below 300% FPL	Extra Help and plan routes, then Pfizer PAP	Pfizer treats its PAP as last resort and may require MPPP enrollment and other-funding denials
Medicare + uncovered Bijuva, Imvexxy, or Femring	Check appeal and plan alternatives, then read the specific opt-out coupon	The coupon can reduce the immediate price but forfeits plan reimbursement and TrOOP credit
Commercial plan covers the exact brand	Current manufacturer commercial card	Most standard cards need the plan to process a covered claim first
Commercial plan excludes a Bayer medicine	Bayer screening plus a formulary exception	Bayer may accept an uncovered exact medicine; the appeal may restore durable plan coverage
Commercial plan excludes another brand	Formulary exception, covered alternative discussion, or live cash comparison	Pfizer excludes commercial insurance, and most cards fail when the plan does not cover the brand
Medicaid, TRICARE, or VA	Plan formulary/appeal, then Pfizer or Bayer screening where applicable	Standard cards exclude government programs; a PAP may still be open
Generic estradiol or micronized progesterone	Compare the exact live cash price before doing paperwork	A cash route may be faster and less expensive than a brand application

This finder gives a route, not an eligibility verdict. It does not need symptoms, a diagnosis, uterus status, age, or medical history because none of those facts determine which organization pays the pharmacy claim. The prescribing decision still belongs to you and your clinician.

How do I get free HRT if I am uninsured?

Answer capsule: Uninsured patients have three current manufacturer routes worth checking: Pfizer for seven listed products, Bayer for medicines on its current roster, and Astellas for Veozah. But check an exact generic cash price first. A free-drug application can be unnecessary when the prescribed generic is already affordable.

Do these in order.

Step 1 — Check the exact generic cash lane

Compare the same drug, strength, quantity, and dosage form at several pharmacies. Include delivery and membership charges. A tablet, patch, vaginal insert, cream, ring, and injection are not interchangeable just because each contains an estrogen.

Do not change the medicine, dose, or route because a website shows a lower price. Take the comparison to the prescriber or pharmacist.

Step 2 — Check the manufacturer's current free-drug roster

If your exact product appears in the Pfizer, Bayer, or Astellas route above, screen against the program's current income, insurance, residence, prescription, and documentation rules. Do not assume that one product family name covers every formulation.

Pfizer's own PDF is the clean example: it separately names Premarin tablets and Premarin Vaginal Cream. Bayer's conflict is the opposite example: Angeliq and Lynkuet do not appear consistently across its two official lists.

Step 3 — Check a nonprofit mail-order pharmacy

Rx Outreach is a nonprofit mail-order pharmacy that publishes upfront prices, does not require insurance or a membership, and offers free delivery across all 50 states. Pfizer names Rx Outreach as one place to check when its PAP is not the answer.

Check the exact medicine and quantity live. A nonprofit label does not guarantee that every drug is stocked or that its price will beat a local pharmacy.

Step 4 — Use a community health center if the prescription itself is also the problem

A federally qualified health center or free clinic may combine the clinical visit with sliding-fee pharmacy access. Search the federal Find a Health Center directory by location.

Manufacturer free medicine may be delivered through the prescriber's office or, for some programs and products, to the patient's home. Confirm the delivery method before assuming a street-address or monthly-shipment rule applies.

I am on Medicare—what can I actually get?

Answer capsule: Start with Extra Help, not a standard manufacturer copay card. In 2026, Extra Help has a $0 Part D deductible and caps prescriptions filled at a participating pharmacy at $5.10 for each generic and $12.65 for each brand. The prescription still must be covered by the plan.

2026 Extra Help protection	What the official Medicare rule says
Part D plan premium	$0
Part D deductible	$0
Generic prescription at a participating pharmacy	Up to $5.10
Brand-name prescription at a participating pharmacy	Up to $12.65
If you have full Medicaid and QMB	No more than $4.90 for each covered drug
After covered Part D out-of-pocket spending reaches the 2026 limit	$0 for each covered drug after you reach $2,100

That last condition matters. Extra Help does not force a plan to cover Estring, Duavee, Bijuva, or any other named medicine. It controls what an eligible member pays for covered prescriptions at participating pharmacies. If the drug is excluded, you still need an exception, a covered alternative discussion, or another route.

What are the 2026 Extra Help income and resource limits?

Answer capsule: Extra Help uses both income and resources. Medicare publishes $23,940 income and $18,090 resources for an individual, and $32,460 income and $36,100 resources for a married couple in the 48 states and D.C. Alaska and Hawaii have higher income schedules. Apply when you are close; Social Security applies exclusions.

Public 2026 screening figure	Individual	Married couple living together
Annual income, 48 states + D.C.	$23,940	$32,460
Countable resources	$18,090	$36,100

The published resource limits already include the burial-expense allowance. Do not add another $1,500 per person on top of them.

For reference, 150% of the 2026 poverty guideline is $29,925 for one person in Alaska and $27,540 in Hawaii. Social Security uses its own countable-income rules and asks territory-specific questions during the application. A table is a screen, not the decision.

Social Security uses countable income after exclusions, not simply the number at the top of a tax return. That is why a person near the line should apply instead of self-denying from a summary table.

→ Apply free at ssa.gov/extrahelp or call Social Security at 1-800-772-1213. You receive Extra Help automatically if you have full-benefit Medicaid, get help from a Medicare Savings Program paying your Part B premium, or receive Supplemental Security Income.

Extra Help is not available in Puerto Rico, the U.S. Virgin Islands, Guam, the Northern Mariana Islands, or American Samoa. Medicare directs residents there to local Medicaid or territory assistance programs.

What other Medicare doors should I check?

A Medicare Savings Program. QMB, SLMB, and QI can help with Medicare costs, and approval for a Medicare Savings Program automatically brings Extra Help. The Extra Help application can also send information to the state to start an MSP application unless you decline.

Your state's pharmaceutical assistance program. State programs vary by residence, age, income, diagnosis, drug, and funding. Use Medicare's current assistance resources or a state .gov page instead of relying on a fixed national count that goes stale.

Pfizer's PAP. Pfizer can accept eligible government-insured patients at or below 300% FPL, but it is a last-resort route. For a covered Part D product, the MPPP and alternate-funding steps can apply.

The Medicare Prescription Payment Plan. This spreads what you owe over the remaining months. It does not lower the total. Use it for cash flow, or because Pfizer requires it in the covered-product situation—not because someone called it savings.

A State Health Insurance Assistance Program counselor. SHIP offers free, unbiased help. The counselor does not sell a plan or take a commission.

Think hard before using a Medicare opt-out coupon

Bijuva, Imvexxy, and Femring have unusual Medicare routes. They can be useful when the plan does not cover the drug or the allowed out-of-pocket amount fits the program rules. They also remove that purchase from the Part D claim.

That means:

• The plan does not reimburse it.
• The amount does not count toward TrOOP.
• You generally stay in the program for that drug for the rest of the calendar year.
• You cannot later ask the plan, an HSA, an FSA, or another payer to reimburse the coupon purchase when the terms prohibit it.

A lower price today can be the right choice. It can also push the point where covered Part D drugs become free further away. Compare the full-year effect before opting out.

Why did my menopause savings card stop working when I turned 65?

Answer capsule: Standard menopause copay cards exclude prescriptions eligible for Medicare, Medicare Advantage, Medicaid, TRICARE, VA, and other government reimbursement. Asking the pharmacy not to bill Medicare usually does not restore eligibility because enrollment or reimbursement eligibility—not merely the submitted claim—triggers the exclusion. Move to Medicare-specific routes instead.

Nobody warns you at the counter. A card works for years. Medicare starts. One month the claim fails, and it feels like you entered the numbers wrong.

You probably did not.

Three details matter:

1. Paying cash does not automatically reactivate a standard card. Commercial card terms are written around government eligibility or reimbursement, not just whether the pharmacist sends the claim to Part D.

2. Some terms exclude Medicare-eligible people even when an employer or retiree plan is still involved. The current Bijuva and Imvexxy commercial terms exclude a Medicare-eligible employee or retiree enrolled in an employer-sponsored prescription plan.

3. A separate Medicare coupon is a different product. Bijuva, Imvexxy, and Femring offer opt-out arrangements with their own rules. They should never be used as proof that a normal commercial card “works with Medicare.”

What replaces the old card is not automatically worse. If you qualify for Extra Help and the drug is covered, the 2026 cap is up to $12.65 for a brand prescription at a participating pharmacy. But you have to apply for the benefit; the pharmacy cannot invent it at the register.

What if I have insurance but my plan will not cover my HRT?

Answer capsule: This is usually a coverage problem, not an assistance problem. Most commercial cards need the plan to cover the exact brand, Pfizer's PAP excludes commercial insurance, and charitable funds require a covered treatment. Bayer is the important exception: it may accept an eligible patient whose exact Bayer medicine is not covered.

Time for the honest part.

The most valuable routes on this page pay us nothing. And for a real share of readers, the honest answer is that no assistance program will take you.

You have insurance through work. The plan excludes the medicine. Then three doors can close at once:

• The commercial card fails because the plan never processes a covered brand claim.
• The free-drug program rejects commercial insurance when the manufacturer uses Pfizer's rule.
• The charitable fund rejects the treatment because there is no covered patient share for the fund to pay.

That is the assistance gap. It is a documented structural hole, not a failure to fill out the form correctly.

Bayer is the exception that has to stay visible. Its Foundation says a patient may qualify when she has no insurance or when her Bayer prescription medicine is not covered. If the medicine is Angeliq or Lynkuet, call first because Bayer's current product lists conflict.

Now the part that gives you your afternoon back:

The assistance gap is a coverage problem wearing an assistance costume. Coverage problems have different tools.

1. 1. Ask for the plan's exact denial reason. “Not covered,” “prior authorization required,” “step therapy,” and “quantity limit” are not the same problem.
2. 2. Request the correct exception or appeal form. Medicare and commercial plans have formulary-exception processes. The prescriber usually needs to explain why covered alternatives are not appropriate for the patient's situation.
3. 3. Ask about an FDA-approved covered alternative. That is a prescribing conversation, not a self-substitution.
4. 4. Compare the exact generic cash lane. When an FDA-approved generic exists for the prescribed product, the live cash price may end the fight faster.

→ If your plan excluded the medicine, move to HRT Cost in 2026 for the coverage, cash-price, and care-cost routes. Do not spend six weeks applying to a program whose written rules exclude you.

What does “pay as little as” actually mean on an HRT savings card?

Answer capsule: It is a conditional floor, not a guaranteed pharmacy price. The amount depends on the plan's allowed cost, deductible, prior authorization, card eligibility, per-fill maximum, annual maximum, pharmacy processing, and whether the manufacturer even publishes a floor. Read the benefit cap beside the headline number.

Program	Manufacturer-published headline	The limitation that changes the price
Pfizer menopause card	As little as $25 on eligible products	Per-fill maxima: Duavee $110, Estring $360, Premarin tablets $120, Prempro $110, Premarin Vaginal Cream $250; combined annual maximum $1,440
Climara Pro savings card	As little as $25 for eligible insured, covered patients	Up to $50 savings per month; eligible cash-paying patients may receive up to $75 off per prescription, subject to a $1,000 annual maximum
Veozah commercial program	$0 first fill and refills as low as $30	Annual maximum up to $4,000; eligibility and claim terms control the final amount
Bijuva commercial card	No universal dollar floor published in the current manufacturer terms	The plan must cover Bijuva; “maximum limitations apply” without one public universal cap
Imvexxy commercial card	No universal dollar floor published in the current manufacturer terms	The plan must cover Imvexxy; “maximum limitations apply” without one public universal cap
Femring Medicare program	Most eligible users may pay as little as $190 for one 90-day ring	It is a Part D opt-out program; no reimbursement and no TrOOP credit
CombiPatch offer	Conflicting official assets: July text says $75 off cash pay; rendered January card says as little as $25	Verify the revision date and call the help desk before relying on either version

Here is how the Pfizer math works. If insurance leaves you owing $200 for Duavee and the card's maximum benefit is $110, the remaining amount is $90—not $25. The headline is reachable only when the amount after insurance is low enough for the card's cap to bring it to the advertised floor.

The deductible still exists. Prior authorization still exists. A plan can still exclude the drug. Some benefit designs do not count manufacturer assistance toward the deductible or out-of-pocket requirement.

Ask the pharmacy for three separate prices before paying:

1. 1. Insurance alone.
2. 2. Insurance plus the current manufacturer card, when eligible.
3. 3. Cash with one current discount route.

The card and cash coupon cannot be stacked. Run them separately and choose the lowest lawful price that does not sacrifice a more valuable insurance benefit without understanding the tradeoff.

The savings card was rejected at the pharmacy. What do I do now?

Answer capsule: A rejected card is not automatically an eligibility denial. Ask the pharmacist for the exact rejection message before leaving. “Prior authorization,” “not covered,” “refill too soon,” “invalid card,” and “benefit maximum reached” require different fixes. The card help desk can often solve a processing problem while the claim is open.

What the pharmacy says	What it usually points to	Who can fix it	What to ask for
“Prior authorization required”	The plan wants clinical documentation before coverage	Prescriber, then plan	The exact PA criteria and submission status
“Not covered” or “non-formulary”	The plan excludes the drug	Plan and prescriber	Formulary-exception instructions and covered alternatives
Covered, but the amount is huge	Deductible, coinsurance, tier, or benefit design	Plan can explain; card may lower it	Insurance-only amount, card amount, deductible status
“Card rejected”	Eligibility, expired identifiers, coding, fill limits, or cap	Card help desk and pharmacy	The exact rejection code and current card terms
“Refill too soon”	Timing, quantity, or last-fill data	Pharmacy or plan	Earliest covered refill date
Card worked before Medicare started	Government-program exclusion	Extra Help, plan coverage, or a true Medicare-specific program	Your new Part D formulary and benefit status
“Maximum benefit reached”	Per-fill or annual manufacturer limit	Card administrator can confirm; it cannot erase the cap	Remaining annual benefit and cash comparison

Ask these two questions in this order:

1. 1. “What is the exact rejection message or code?” Not “it did not work.” The actual text.
2. 2. “Can you quote insurance alone, the current card if eligible, and cash separately?”

If the problem is the card, call the manufacturer help desk from the counter. Download a fresh card from the manufacturer's site instead of copying old BIN, PCN, group, or ID numbers from a coupon page. Manufacturers revise offers, and a stale identifier looks like an eligibility rejection.

Are services that charge a monthly fee to apply legitimate?

Answer capsule: Some are lawful paperwork services, and a person may decide the clerical help is worth paying for. But the manufacturer programs on this page accept direct applications without an enrollment-service fee. A paid service also cannot create a free-drug program for a medicine the manufacturer does not currently list.

This is the part we would want a friend to say out loud.

A search for almost any expensive brand plus “patient assistance” can produce an enrollment page with that exact drug in the headline. The page may be selling application help, not documenting a manufacturer free-drug program for that medicine.

Medication	What the current manufacturer route actually shows
Bijuva	Commercial card and a separate Medicare opt-out coupon; no current manufacturer free-drug PAP found
Imvexxy	Commercial card and a separate Medicare opt-out coupon; no current manufacturer free-drug PAP found
CombiPatch	Manufacturer savings offer with conflicting current assets; no current manufacturer free-drug PAP found
Vagifem	Not listed on Novo Nordisk's current PAP roster checked in August 2026
Estrace Vaginal Cream	Not listed on AbbVie's current PAP or savings rosters checked in August 2026

That does not make every paid service fraudulent. It means you should ask one question before giving it a card number:

“Which manufacturer program will supply this exact medicine free, and can you show me the manufacturer's current page?”

If the answer is a copay card, cash coupon, or vague “we work with advocates,” you are not buying access to a hidden free-drug program. You are buying paperwork help.

Free places to search include NeedyMeds, the Medicine Assistance Tool, RxAssist, BenefitsCheckUp, SHIP, and the federal Eldercare Locator.

What about charitable foundations for menopause medication?

Answer capsule: Charitable foundations usually require active insurance, a covered diagnosis and treatment, income within the fund's rule, and an open fund. They do not replace insurance for an uninsured patient. As of August 2026, the relevant HealthWell postmenopausal osteoporosis Medicare fund is temporarily closed to new patients.

The HealthWell Postmenopausal Osteoporosis Medicare Access Fund currently shows:

• Temporarily closed to new patients.
• A maximum award of $1,000 when the fund is open and the applicant qualifies.
• An income limit up to 500% of the federal poverty level.
• A defined list of osteoporosis treatments—not a general fund for hot flashes, night sweats, or vaginal symptoms.

Existing grants can remain active even when the fund closes to new applicants. Fund status can change with donations, so check on the day you apply.

The PAN Foundation and Patient Advocate Foundation combined their assistance operations into TotalAssist in July 2026. The current phone number is 1-866-512-3861. Use its live disease-fund directory instead of an old PAN contact page.

We did not find a current major charitable fund dedicated broadly to vasomotor symptoms or genitourinary syndrome of menopause. That is a dated search result, not a permanent declaration. Fund names and status change; check the current directories before ruling the route out.

What documents will they ask for, and how long does it take?

Answer capsule: Expect a valid prescription, patient information, prescriber information, insurance details, and income or coverage documents when the program requires them. Timing is not universal. Bayer says a complete application is usually reviewed within two business days; Pfizer and Astellas should be asked for current product-specific timing before you plan a refill.

Build one packet before calling the prescriber's office:

• Exact medicine name, dosage form, strength, quantity, and directions from the prescription.
• Prescriber's name, office address, phone, fax, and identifying information requested on the form.
• Every active insurance card, front and back.
• Income documents accepted by that program, such as a tax return, W-2, or pay information when requested.
• Prior-authorization, noncoverage, or denial documents.
• Proof of Medicare Prescription Payment Plan enrollment when Pfizer requires it.
• Denial evidence from alternate funding sources when Pfizer requires it.
• Household size and contact information.
• The delivery address or clinician-office details required for that product.

The sentence to use with the office:

“I am applying to the [manufacturer] patient assistance program for [exact drug]. The application has a prescriber section and may need the prescription sent to the program. Can I send the form today, and who should I follow up with?”

Naming the manufacturer, medicine, and task turns a vague favor into a defined clerical job.

One honest note about timing: even when a manufacturer reviews a complete form quickly, missing provider information, a denied claim, income documents, shipping setup, or an alternate-funding requirement can slow the actual medicine. These programs are not a safe promise for a prescription needed tomorrow.

If a refill gap is approaching, call the program and prescriber before stopping. Ask the pharmacist for a lawful short-term cash comparison while the application is pending. Never stop, stretch, split, substitute, or change a prescription because of this page.

Does patient assistance pay for the visit, labs, or telehealth membership?

Answer capsule: Usually no. The manufacturer PAPs, commercial cards, cash offers, and Medicare coupons mapped here are attached to a named prescription product. The consultation, telehealth membership, laboratory work, follow-up visit, pharmacy shipping, and other care charges sit in a separate cost layer unless a program expressly says otherwise.

Think about the bill as two stacks:

The medicine layer: what the pharmacy or manufacturer charges for the prescription. This is what the programs on this page mainly address.

The care layer: the clinician visit, membership, lab work, follow-up, administrative forms, and renewal appointment. Prescription assistance usually does not touch it.

That distinction catches people out. Free Premarin does not automatically create a free annual appointment, and a Veozah commercial card does not pay for the lab monitoring or clinical follow-up the prescriber orders.

If the care layer is the problem, use HRT Cost in 2026 to compare the full care model instead of chasing a medicine coupon that cannot reach the larger bill.

What if I do not have a prescriber yet?

Answer capsule: A manufacturer free-drug application still needs a valid prescription, and most require prescriber participation. Extra Help lowers Part D costs but does not create a prescription. If the actual bottleneck is finding a clinician who can evaluate you and prescribe an appropriate FDA-approved medicine, solve that before starting the application.

Read this before paying for an online visit. Medicare and Medicaid users have fewer compatible cash-telehealth routes. Midi does not submit Medicare claims for its services and does not treat Medicaid or Medi-Cal patients. Sesame's terms require federal-program beneficiaries, including Medicare, Medicaid, and TRICARE members, not to use the service. Start with your existing clinician, plan directory, health center, or SHIP before buying a visit you cannot use.

Disclosure: the Midi link below is an affiliate link. If you start care through it, The HRT Index may earn a commission at no cost to you. The Sesame and Hers links go directly to the providers. That does not change the order above; the strongest assistance routes on this page earn us nothing.

Answer capsule: These provider routes solve the clinical-access problem, not the manufacturer-program rules. Current public pricing and payer limits are shown where verified. No provider below is represented as willing to prescribe a particular brand, complete a particular PAP form, or continue an existing medicine. Ask those questions before paying.

Provider route	Current verified fit	Medicine and labs	Payer or access limits	What to verify before paying
Midi Health	Commercial-insurance or self-pay menopause care; current self-pay pricing is $250 for a first visit and $150 for a follow-up	Prescribing and testing depend on clinical need; additional costs can apply	Medicare users are self-pay and neither Midi nor the patient may submit related claims; no Medicaid or Medi-Cal treatment	Network status, state availability, exact brand willingness, lab cost, and PAP-form support
Sesame	Cash-pay visit when the patient needs an evaluation and, if appropriate, a prescription sent to a chosen pharmacy	Medication is not included; the menopause page says basic lab work is included when the clinician determines it is necessary, with state exceptions and possible charges	Does not accept insurance; terms exclude Medicare, Medicaid, TRICARE, and other federal-program beneficiaries	Live visit price, clinician/state availability, exact medicine, labs, and cancellation terms
Hers	Bundled online menopause treatment for eligible patients who prefer medication delivery	Offers certain FDA-approved estradiol and progesterone options when clinically appropriate; exact selection and checkout price vary	Not available in every state; it is not a route into a manufacturer PAP for an outside brand	State access, exact medication, total recurring price, renewal and cancellation terms, and whether the included model fits your goal

Source: Midi pricing and payer rules, Sesame menopause care, Sesame Terms of Service, and Hers menopause care.

Midi Health — when commercial insurance or a menopause-focused self-pay visit fits. Midi is a clinical service, not a manufacturer assistance program. Check whether Midi works with your plan and state →

Sesame — when you are paying cash for a visit and want the prescription sent to a pharmacy. Medication cost is separate. See current menopause visit pricing and availability →

Hers — when you prefer an included-medication model rather than a separate pharmacy-assistance application. See the current treatment options and state availability →

We have not verified that any of these providers will prescribe or continue the exact brand named elsewhere on this page, complete its manufacturer form, or accept a transfer without a new clinical decision. Ask at intake before the charge is final.

Compounded-only providers are not featured here because manufacturer PAPs in this article are tied to named FDA-approved products. A clinic discount on a compounded prescription is a different business arrangement.

Do HRT patient assistance programs cover compounded hormones?

Answer capsule: No manufacturer program described here treats a compounded preparation as one of its FDA-approved brand products. Compounded drugs are not FDA-approved, and FDA does not verify their safety, effectiveness, or quality before marketing. A clinic or pharmacy discount for a compounded prescription is not a manufacturer patient assistance program.

A compounded prescription is prepared for an individual patient by a pharmacy or other permitted compounder. It can meet an important need when an FDA-approved drug is not medically appropriate, but it is not an FDA-approved product, not a generic drug, and not automatically interchangeable with one.

That separation is practical, not rhetorical. A Pfizer application for Estring cannot be used to pay for a compounded estradiol product. A Bayer Foundation approval for Climara Pro does not create coverage for a custom patch. A compounding-clinic membership discount remains a clinic discount.

Source: FDA, Compounding and the FDA: Questions and Answers.

Is there an assistance program for testosterone prescribed to women?

Testosterone is a Schedule III controlled substance in the United States and requires a prescription. FDA's current testosterone page says FDA-approved testosterone products are approved only for use in men; there is no FDA-approved testosterone product indicated for women.

That blocks the Pfizer-style PAP route described here when the program requires an FDA-approved indication. It does not mean a clinician can never prescribe testosterone off-label to a woman. It means this page cannot present a manufacturer free-drug program for an FDA-approved women's testosterone product that does not exist.

Sources: DEA Schedule III examples and FDA testosterone information.

How did The HRT Index verify this page?

Answer capsule: We read current manufacturer eligibility pages, dated product rosters, card terms, Medicare guidance, Social Security tables, and FDA materials. Presence claims are tied to a primary source. Absence claims are limited to the current manufacturer rosters checked. Where two official sources conflict, the conflict stays visible instead of being resolved by guesswork.

Claim area	Primary evidence checked	Verification result	Refresh trigger
Pfizer free-drug eligibility	Pfizer's 2026 eligibility page	300% FPL; uninsured or government-insured; commercial excluded; FDA-approved indication; alternate-funding rules	Monthly through the 2026–2027 transition
Pfizer product roster	July 2026 Pfizer PAP PDF	Seven relevant products, including separate Premarin tablet and cream entries	Monthly and whenever the PDF date changes
Pfizer commercial savings	Pfizer menopause savings terms	Product-specific per-fill maxima and $1,440 combined annual cap	Monthly and at card expiration
Bayer eligibility	Bayer Foundation FAQ	No insurance or exact Bayer medicine not covered; 300% FPL for most medicines	Quarterly and on form revision
Bayer product roster	Live Find Help tool and dated product page	Conflict: Angeliq appears only in the tool; Lynkuet appears only on the dated page	Monthly until reconciled
Veozah assistance	Astellas patient-support pages	Commercial and uninsured routes verified; no public universal PAP income percentage	Quarterly and on terms update
Bijuva and Imvexxy	Current Mayne commercial cards and Medicare terms	Commercial card plus separate Part D opt-out route; no public universal commercial dollar floor	Monthly near expiration and at calendar year change
Femring	Current Medicare savings terms	Medicare-only opt-out route with as-low-as $190 for a 90-day ring	Quarterly and at calendar year change
CombiPatch	Current official manufacturer asset	Live conflict between July $75 cash offer text and January $25 commercial/cash rendered card	Before every refresh until the asset is reconciled
Extra Help	Medicare 2026 guidance and SSA application	Income, resources, participating-pharmacy caps, automatic eligibility, and $2,100 limit verified	Annually after the CMS/SSA update
Federal poverty figures	2026 HHS poverty guidelines	300% table recomputed from official schedules	Every January
Charitable-fund status	HealthWell fund page and TotalAssist	HealthWell fund closed to new patients; TotalAssist is the current combined portal	Monthly
Compounded-drug status	FDA compounding guidance	Compounded drugs are not FDA-approved and are not generics	On FDA policy change
Testosterone status	DEA Schedule III examples and FDA testosterone information	Schedule III; FDA-approved testosterone products are approved only for use in men, not women	On federal scheduling or approval change
Individual plan coverage	Not knowable from a national page	Not verified. The plan formulary and live claim control	Every enrollment year and plan change
Individual program approval	Only the program can decide	Not verified. This page screens routes, not people	At application

The HRT Index Verification Standard

This page follows The HRT Index Verification Standard: read every published price and term, separate FDA-approved products from compounded preparations, verify state availability and insurance rules, and re-check on a fixed schedule—top programs monthly and the full roster quarterly.

When care providers appear, we evaluate them on five pillars in this order: clinical legitimacy, care quality, medication fit, price transparency, and access. We do not publish invented per-provider scores.

Who produced this page: The HRT Index. This is editorial research. It has not been medically reviewed by a clinician and is not medical advice. We did not enroll in a manufacturer program, adjudicate a pharmacy claim, receive medicine, or impersonate an applicant.

Found something wrong? Send the current primary source and the date you saw it. We will correct the claim and update the verification date only after rechecking the underlying program.

Frequently asked questions about HRT patient assistance programs

Is there really a patient assistance program for HRT?

Yes, for specific FDA-approved products and eligible patients. Pfizer currently lists seven relevant free medicines. Bayer and Astellas have separate eligibility systems. Other brands may have a commercial card, cash offer, Medicare opt-out coupon, or no current manufacturer route.

Can I get Premarin for free?

Possibly. Pfizer's July 2026 PAP PDF separately lists Premarin tablets and Premarin Vaginal Cream. You still need to meet the current income, insurance, prescription, indication, residence, affordability, and documentation rules. Commercial insurance disqualifies you from Pfizer's PAP.

Does Medicare cover hormone replacement therapy?

Coverage depends on the exact drug and the individual Part D or Medicare Advantage formulary. Extra Help can reduce what an eligible person pays for a covered prescription at a participating pharmacy, but it does not force the plan to cover every HRT brand.

What is the income limit for HRT patient assistance in 2026?

Pfizer uses 300% FPL. Bayer says 300% applies to most medicines. In the 48 states and D.C., that is $47,880 for one person and $64,920 for two. Alaska and Hawaii use higher schedules. Astellas does not publish a universal Veozah PAP percentage on its public page.

Can I use a manufacturer copay card and GoodRx together?

No. Manufacturer card terms and cash discount terms generally prohibit stacking. Ask the pharmacy to price each route separately, then use the lowest eligible route after considering insurance credit.

Do I have to be uninsured?

Not always. Pfizer accepts eligible uninsured or government-insured patients and excludes commercial insurance. Bayer may accept a patient with no insurance or whose exact Bayer medicine is not covered. Astellas publishes a $0 route for eligible uninsured Veozah patients. Each program has its own rules.

Can a commercially insured patient get free medicine when the plan excludes the drug?

Sometimes with Bayer; generally not with Pfizer. Bayer's Foundation expressly includes some patients whose Bayer prescription is not covered. Pfizer excludes commercially insured patients even when the plan pays nothing. For other brands, the primary route is usually a formulary exception or cash comparison.

How long does approval take?

There is no honest universal answer. Bayer says complete applications are usually reviewed within two business days. Missing prescriber information or documents can extend the process, and review is not the same as medicine arriving. Ask the exact program for current timing before planning a refill.

Does my prescriber have to complete anything?

For manufacturer free-drug programs, expect a valid prescription and prescriber participation. The exact form and delivery process vary. Extra Help is different: it is an application to Social Security and does not require a clinician to establish financial eligibility.

What if my income is just over the published line?

Do not change a number or misstate income. Call the program and ask how it defines household and countable income. For Extra Help, Social Security applies income exclusions, so someone near the public table should apply rather than self-deny.

Can I apply to more than one assistance source?

Yes, and Pfizer may require it. Its 2026 rules say applicants must use applicable alternate funding resources first and may need denial documentation before Pfizer considers the PAP.

Do these programs cover compounded hormones?

No. The manufacturer programs here are tied to named FDA-approved products. Compounded drugs are not FDA-approved and are not equivalent to a manufacturer brand for program billing.

Is there a patient assistance program for testosterone for women?

Not through an FDA-approved women's testosterone product, because no such U.S. product is currently approved. Testosterone is Schedule III and requires a prescription. Off-label prescribing is a clinical decision, but it does not create an FDA-approved indication for a manufacturer PAP that requires one.

Is there a program for generic estradiol or micronized progesterone?

A manufacturer free-drug program is usually not the first route for generics. Compare the exact FDA-approved generic, strength, quantity, pharmacy, and shipping cost live. Do not use a lower price to self-switch formulation or dose.

What happens if I lose commercial insurance during the year?

Your eligibility lane can change immediately. Losing commercial coverage may open an uninsured PAP route that was closed before. Recheck the manufacturer rules using the date coverage ends, and ask about bridge coverage or a special enrollment period.

Does free medicine always ship to my house?

No. Pfizer says free medicines may be supplied through the clinician's office or, in some cases, at home. Astellas describes direct shipment for its eligible uninsured Veozah route. Confirm the product-specific delivery method before choosing an address.

Do I have to reapply every year?

Many manufacturer and foundation programs use enrollment periods and require renewal, but the term is program-specific. Check the approval letter and calendar the renewal before the last covered shipment. Do not assume every program runs exactly 12 months.

My plan denied the medicine. Is that the same as needing assistance?

No. A denial is a coverage decision. Prior authorization, step therapy, quantity limits, and non-formulary exclusions each have a plan process. Assistance can help with cost after coverage, but it does not automatically overturn a denial.

What is the difference between Extra Help and a manufacturer PAP?

Extra Help is a federal Medicare benefit that can lower costs across covered Part D prescriptions. A manufacturer PAP supplies one company's named medicine to an approved patient. A Medicare beneficiary may use both routes in sequence when the rules allow, but they are not interchangeable.

Will a Medicare opt-out coupon count toward the $2,100 Part D limit?

The Bijuva, Imvexxy, and Femring programs reviewed here say no. The purchase is outside the plan and does not count toward TrOOP. Compare the immediate coupon price with the value of staying inside Part D for the full year.

What should I do next based on my situation?

Answer capsule: Match the payer, coverage status, exact medicine, and income before filling out a form. Start with benefits that protect insurance credit, move to the manufacturer that actually makes the drug, and use cash or opt-out routes only after seeing the tradeoff. The first move below is designed to prevent a dead-end application.

Your situation	Your first move today
Uninsured + listed Pfizer product + income at or below 300% FPL	Call Pfizer at 1-844-989-7284
Uninsured or exact Bayer drug not covered + income within Bayer's rule	Use Bayer's Find Help tool and call 1-866-228-7723, especially for Angeliq or Lynkuet
Uninsured + Veozah	Call Astellas at 1-866-239-1637
Medicare + income/resources near the 2026 limits	Apply for Extra Help
Medicare + full Medicaid, SSI, or an MSP	Confirm automatic Extra Help and check the plan formulary
Medicare + uncovered Bijuva, Imvexxy, or Femring	Compare an exception and covered alternatives before accepting the opt-out coupon
Commercial insurance + covered brand	Download the current manufacturer card and ask for three separate prices
Commercial insurance + excluded brand	File the formulary exception; check Bayer separately when it makes the exact drug
Generic estradiol or micronized progesterone	Check the exact live cash price and HRT Cost in 2026
Card rejected at the counter	Ask for the exact rejection code before leaving
No prescriber	Use the plan directory, a health center, or Find My HRT Path before paying for the wrong care model

One last thing, because it needs saying.

Needing help paying for medicine is not a character flaw. These programs exist because a prescription can be clinically appropriate and still be financially impossible. The paperwork is confusing because the systems were built by different organizations with different definitions of “assistance,” not because you failed to understand something obvious.

You already did the hard part: you noticed the problem, found the exact medicine, and started looking for a way through. Now you have the order. This is paperwork. Paperwork you can win.

Still not sure which HRT path fits your situation? Use Find My HRT Path to get a personalized starting point—and a flag when online care is not the right place to begin.

---

Educational only—not medical advice. This page is editorial research and has not been medically reviewed by a clinician. Eligibility is determined only by the organization operating each program. Prices, product rosters, card terms, plan coverage, and fund status can change. Check the current primary source before relying on a number. FDA-approved products and compounded preparations are not treated as equivalent. Last verified August 2026.